Regulators of G-protein signaling 4 in adrenal gland: Localization, regulation, and role in aldosterone secretion

Journal of Endocrinology

Volumn 194, Issue 2, 2007, Pages 429-440

  Romero, Damian G ^a,b   Zhou, Ming Yi ^c   Yanes, Licy L ^a   Plonczynski, Maria W ^a   Washington, Tanganika R ^a,b   Gomez Sanchez, Celso E ^a,b   Gomez Sanchez, Elise P ^a,b  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ALDOSTERONE SYNTHASE; ANGIOTENSIN II; MESSENGER RNA; PROTEIN KINASE (CALCIUM,CALMODULIN); PROTEIN KINASE C; RGS4 PROTEIN;

ADRENAL CORTEX CELL; ADRENAL GLAND; ALDOSTERONE RELEASE; ANIMAL EXPERIMENT; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; NEGATIVE FEEDBACK; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; REGULATORY MECHANISM; RETROVIRUS; SIGNAL TRANSDUCTION; SODIUM RESTRICTION; STEROIDOGENESIS; UPREGULATION; VIRUS INFECTION; ZONA GLOMERULOSA;

ADOLESCENT; ADULT; ALDOSTERONE; ANGIOTENSIN II; ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL LINE; DIET, SODIUM-RESTRICTED; FEMALE; GENETIC VECTORS; GTP-BINDING PROTEINS; HUMANS; MALE; MIDDLE AGED; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; RETROVIRIDAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RGS PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSDUCTION, GENETIC; UP-REGULATION; ZONA GLOMERULOSA;

EID: 34547867358     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/JOE-07-0153     Document Type: Article

References (71)

1. Abramow-Newerly M, Roy AA, Nunn C & Chidiac P 2006 RGS proteins have a signalling complex: interactions between RGS proteins and GPCRs, effectors, and auxiliary proteins. Cellular Signalling 18 579-591.
2. Barrett PQ, Bollag WB, Isales CM, McCarthy RT & Rasmussen H 1989 Role of calcium in angiotensin II-mediated aldosterone secretion. Endocrine Reviews 10 496-518.
3. Bassett MH, White PC & Rainey WE 2004 The regulation of aldosterone synthase expression. Molecular and Cellular Endocrinology 217 67-74.
4. Berman DM & Gilman AG 1998 Mammalian RGS proteins: barbarians at the gate. Journal of Biological Chemistry 273 1269-1272.
5. Berman DM, Kozasa T & Gilman AG 1996 The GTPase-activating protein RGS4 stabilizes the transition state for nucleotide hydrolysis. Journal of Biological Chemistry 271 27209-27212.
6. Bianchi C, Gutkowska J, De Lean A, Ballak M, Anand-Srivastava MB, Genest J & Cantin M 1986 Fate of [1251]angiotensin II in adrenal zona glomerulosa cells. Endocrinology 118 2605-2607.
7. Bird IM, Hanley NA, Word RA, Mathis JM, McCarthy JL, Mason JI & Rainey WE 1993 Human NCI-H295 adrenocortical carcinoma cells: a model for angiotensin-II-responsive aldosterone secretion. Endocrinology 133 1555-1561.
8. Bird IM, Mason JI & Rainey WE 1994 Regulation of type 1 angiotensin II receptor messenger ribonucleic acid expression in human adrenocortical carcinoma H295 cells. Endocrinology 134 2468-2474.
9. 2+ at the level of steroidogenic cytochromes P450 and 3 beta HSD expression in H295R cells. Endocrine Research 24 345-354.
10. Blumer KJ 2005 Rgs4. AfCS-Nature Molecule Pages doi:10.1038/ mp.a000134.000101.
11. Boulay G, Chretien L, Richard DE & Guillemette G 1994 Short-term desensitization of the angiotensin II receptor of bovine adrenal glomerulosa cells corresponds to a shift from a high to a low affinity state. Endocrinology 135 2130-2136.
12. Burchett SA 2000 Regulators of G protein signaling: a bestiary of modular protein binding domains. Journal of Neurochemistry 75 1335-1351.
13. Cho H, Harrison K, Schwartz O & Kehrl JH 2003 The aorta and heart differentially express RGS (regulators of G-protein signalling) proteins that selectively regulate sphingosine 1-phosphate, angiotensin II and endothelin-1 signalling. Biochemical Journal 371 973-980.
14. Chowdari KV, Mirnics K, Semwal P, Wood J, Lawrence E, Bhatia T, Deshpande SN, B KT, Ferrell RE, Middleton FA et al. 2002 Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Human Molecular Genetics 11 1373-1380.
15. Condon JC, Pezzi V, Drummond BM, Yin S & Rainey WE 2002 Calmodulin-dependent kinase I regulates adrenal cell expression of aldosterone synthase. Endocrinology 143 3651-3657.
16. Daido H, Zhou MY, Gomez-Sanchez EP & Gomez-Sanchez CE 2003 Interferon-inducible genes in the rat adrenal gland and vascular smooth muscle cells. Molecular and Cellular Endocrinology 200 81-87.
17. Davydov IV & Varshavsky A 2000 RGS4 is arginylated and degraded by the N-end rule pathway in vitro. Journal of Biological Chemistry 275 22931-22941.
18. Denner K, Rainey WE, Pezzi V, Bird IM, Bernhardt R & Mathis JM 1996 Differential regulation of 11 beta-hydroxylase and aldosterone synthase in human adrenocortical H295R cells. Molecular and Cellular Endocrinology 121 87-91.
19. 2+ signaling. American Journal of Physiology 269 F751-F760.
20. Gambaryan S, Butt E, Tas P, Smolenski A, Allolio B & Walter U 2006 Regulation of aldosterone production from zona glomerulosa cells by ANG II and cAMP: evidence for PKA-independent activation of CaMK by cAMP. American Journal of Physiology. Endocrinology and Metabolism 290 E423-E433.
21. Ganguly A & Davis JS 1994 Role of calcium and other mediators in aldosterone secretion from the adrenal glomerulosa cells. Pharmacological Reviews 46 417-447.
22. Gomez-Sanchez CE, Foecking MF, Ferris MW, Chavarri MR, Uribe L & Gomez-Sanchez EP 1987 The production of monoclonal antibodies against aldosterone. Steroids 49 581-587.
23. Hajnoczky G, Varnai P, Buday L, Farago A & Spat A 1992 The role of protein kinase-C in control of aldosterone production by rat adrenal glomerulosa cells:activation of protein kinase-C by stimulation with potassium. Endocrinology 130 2230-2236.
24. Harris IS, Treskov I, Rowley MW, Heximer S, Kaltenbronn K, Finck BN, Gross RW, Kelly DP, Blumer KJ & Muslin AJ 2004 G-protein signaling participates in the development of diabetic cardiomyopathy. Diabetes 53 3082-3090.
25. Hepler JR, Berman DM, Gilman AG & Kozasa T 1997 RGS4 and GAIP are GTPase-activating proteins for Gq alpha and block activation of phospholipase C beta by gamma-thio-GTP-Gq alpha. PNAS 94 428-432.
26. + -induced aldosterone secretion from human adrenocortical NCI-H295 cells. Hypertension 33 1025-1030.
27. Hollinger S & Hepler JR 2002 Cellular regulation of RGS proteins: modulators and integrators of G protein signaling. Pharmacological Reviews 54 527-559.
28. Ingi T & Aoki Y 2002 Expression of RGS2, RGS4 and RGS7 in the developing postnatal brain. European Journal of Neuroscience 15 929-936.
29. Ingi T, Krumins AM, Chidiac P, Brothers GM, Chung S, Snow BE, Barnes CA, Lanahan AA, Siderovski DP, Ross EM et al. 1998 Dynamic regulation of RGS2 suggests a novel mechanism in G-protein signaling and neuronal plasticity. Journal of Neuroscience 18 7178-7188.
30. Larminie C, Murdock P, Walhin JP, Duckworth M, Blumer KJ, Scheideler MA & Garnier M 2004 Selective expression of regulators of G-protein signaling (RGS) in the human central nervous system. Brain Research. Molecular Brain Research 122 24-34.
31. Lee MJ, Tasaki T, Moroi K, An JY, Kimura S, Davydov IV & Kwon YT 2005 RGS4 and RGS5 are in vivo substrates of the N-end rule pathway. PNAS 102 15030-15035.
32. LeHoux JG & Lefebvre A 1998 Transcriptional activity of the hamster CYP11B2 promoter in NCI-H295 cells stimulated by angiotensin II, potassium, forskolin and bisindolylmaleimide. Journal of Molecular Endocrinology 20 183-191.
33. LeHoux JG & Lefebvre A 2006 Novel protein kinase C-epsilon inhibits human CYP11B2 gene expression through ERK1/2 signalling pathway and JunB. Journal of Molecular Endocrinology 36 51-64.
34. LeHoux JG, Dupuis G & Lefebvre A 2001 Control of CYP11B2 gene expression through differential regulation of its promoter by atypical and conventional protein kinase C isoforms. Journal of Biological Chemistry 276 8021-8028.
35. Merritt JE, Armstrong WP, Benham CD, Hallam TJ, Jacob R, Jaxa-Chamiec A, Leigh BK, McCarthy SA, Moores KE & Rink TJ 1990 SK&F 96365, a novel inhibitor of receptor-mediated calcium entry. Biochemical Journal 271 515-522.
36. Mirnics K, Middleton FA, Stanwood GD, Lewis DA & Levitt P 2001 Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Molecular Psychiatry 6 293-301.
37. Mittmann C, Chung CH, Hoppner G, Michalek C, Nose M, Schuler C, Schuh A, Eschenhagen T, Weil J, Pieske B et al. 2002 Expression of ten RGS proteins in human myocardium: functional characterization of an upregulation of RGS4 in heart failure. Cardiovascular Research 55 778-786.
38. Morris DW, Rodgers A, McGhee KA, Schwaiger S, Scully P, Quinn J, Meagher D, Waddington JL, Gill M & Corvin AP 2004 Confirming RGS4 as a susceptibility gene for schizophrenia. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 125 50-53.
39. Naville D, Lebrethon MC, Kermabon AY, Rouer E, Benarous, R & Saez JM 1993 Characterization and regulation of the angiotensin II type-1 receptor (binding and mRNA) in human adrenal fasciculata-reticularis cells. FEBS Letters 321 184-188.
40. Neubig RR & Siderovski DP 2002 Regulators of G-protein signalling as new central nervous system drug targets. Nature Reviews. Drug Discovery 1 187-197.
41. Newton-Cheh C, Guo CY, Gona P, Larson MG, Benjamin EJ, Wang TJ, Kathiresan S, O'Donnell CJ, Musone SL, Camargo AL et al. 2007 Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample. Hypertension 49 846-856.
42. O'Donovan MC, Williams NM & Owen MJ 2003 Recent advances in the genetics of schizophrenia. Human Molecular Genetics 12 R125-R133.
43. Ouali R, Berthelon MC, Begeot M & Saez JM 1997 Angiotensin II receptor subtypes AT1 and AT2 are down-regulated by angiotensin II through AT1 receptor by different mechanisms. Endocrinology 138 725-733.
44. Owen VJ, Burton PB, Mullen AJ, Birks EJ, Barton P & Yacoub MH 2001 Expression of RGS3, RGS4 and Gi alpha 2 in acutely failing donor hearts and end-stage heart failure. European Heart Journal 22 1015-1020.
45. Penhoat A, Jaillard C, Crozat A & Saez JM 1988 Regulation of angiotensin II receptors and steroidogenic responsiveness in cultured bovine fasciculata and glomerulosa adrenal cells. European Journal of Biochemistry 172 247-254.
46. Pezzi V, Clyne CD, Ando S, Mathis JM & Rainey WE 1997 Ca(2 +)- regulated expression of aldosterone synthase is mediated by calmodulin and calmodulin-dependent protein kinases. Endocrinology 138 835-838.
47. Pfaffl MW 2001 A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Research 29 e45.
48. Rainey WE, Bird IM & Mason JI 1994 The NCI-H295 cell line: a pluripotent model for human adrenocortical studies. Molecular and Cellular Endocrinology 100 45-50.
49. Rainey WE, Saner K & Schimmer BP 2004 Adrenocortical cell lines. Molecular and Cellular Endocrinology 228 23-38.
50. Richard DE, Chretien L, Caron M & Guillemette G 1997 Stimulation of the angiotensin II type I receptor on bovine adrenal glomerulosa cells activates a temperature-sensitive internalization-recycling pathway. Molecular and Cellular Endocrinology 129 209-218.
51. Riddle EL, Schwartzman RA, Bond M & Insel PA 2005 Multi-tasking RGS proteins in the heart: the next therapeutic target? Circulation Research 96 401-411.
52. Rogers JH, Tamirisa P, Kovacs A, Weinheimer C, Courtois M, Blumer KJ, Kelly DP & Muslin AJ 1999 RGS4 causes increased mortality and reduced cardiac hypertrophy in response to pressure overload. Journal of Clinical Investigation 104 567-576.
53. Romero DG, Plonczynski M, Vergara GR, Gomez-Sanchez EP & Gomez-Sanchez CE 2004 Angiotensin II early regulated genes in H295R human adrenocortical cells. Physiological Genomics 19 106-116.
54. Romero DG, Plonczynski M, Gomez-Sanchez EP, Yanes LL & Gomez-Sanchez CE 2006 RGS2 is regulated by angiotensin II and functions as a negative feedback of aldosterone production in H295R human adrenocortical cells. Endocrinology 147 3889-3897.
55. Ross EM & Wilkie TM 2000 GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins. Annual Review of Biochemistry 69 795-827.
56. Rossi GP, Sacchetto A, Pavan E, Palatini P, Graniero GR, Canali C & Pessina AC 1997 Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma. Circulation 95 1471-1478.
57. Rossi GP, Bernini G, Desideri G, Fabris B, Ferri C, Giacchetti G, Letizia C, Maccario M, Mannelli M, Matterello MJ et al. 2006 Renal damage in primary aldosteronism: results of the PAPY Study. Hypertension 48 232-238.
58. Roy AA, Lemberg KE & Chidiac P 2003 Recruitment of RGS2 and RGS4 to the plasma membrane by G proteins and receptors reflects functional interactions. Molecular Pharmacology 64 587-593.
59. Rozen S & Skaletsky H 2000 Primer3 on the WWW for general users and for biologist programmers. Methods in Molecular Biology 132 365-386.
60. Sato M, Blumer JB, Simon V & Lanier SM 2006 Accessory proteins for G proteins: partners in signaling. Annual Review of Pharmacology and Toxicology 46 151-187.
61. Spat A & Hunyady L 2004 Control of aldosterone secretion: a model for convergence in cellular signaling pathways. Physiological Reviews 84 489-539.
62. Tamirisa P, Blumer KJ & Muslin AJ 1999 RGS4 inhibits G-protein signaling in cardiomyocytes. Circulation 99 441-447.
63. Tanabe A, Naruse M, Naruse K, Hase M, Yoshinnoto T, Tanaka M, Seki T & Demura H 1997 Left ventricular hypertrophy is more prominent in patients with primary aldosteronism than in patients with other types of secondary hypertension. Hypertension Research 20 85-90.
64. Taymans JM, Kia HK, Claes R, Cruz C, Leysen J & Langlois X 2004 Dopamine receptor-mediated regulation of RGS2 and RGS4 mRNA differentially depends on ascending dopamine projections and time. European Journal of Neuroscience 19 2249-2260.
65. Vasan RS, Evans JC, Larson MG, Wilson PW, Meigs JB, Rifai N, Benjamin EJ & Levy D 2004 Serum aldosterone and the incidence of hypertension in nonhypertensive persons. New England Journal of Medicine 351 33-41.
66. De Vries L & Gist Farquhar M 1999 RGS proteins: more than just GAPs for heterotrimeric G proteins. Trends in Cell Biology 9 138-144.
67. De Vries L, Zheng B, Fischer T, Elenko E & Farquhar MG 2000 The regulator of G protein signaling family. Annual Review of Pharmacology and Toxicology 40 235-271.
68. Watson N, Linder ME, Druey KM, Kehrl JH & Blumer KJ 1996 RGS family members: GTPase-activating proteins for heterotrimeric G-protein alpha-subunits. Nature 383 172-175.
69. Wotus C, Levay-Young BK, Rogers L, Gomez-Sanchez CE & Engeland WC 1998 Development of adrenal zonation in fetal rats defined by expression of aldosterone synthase and 11β-hydroxylase. Endocrinology 139 4397-4403.
70. Zhang S, Watson N, Zahner J, Rottman JN, Blumer KJ & Muslin AJ 1998 RGS3 and RGS4 are GTPase activating proteins in the heart. Journal of Molecular and Cellular Cardiology 30 269-276.
71. Zhou MY, Gomez-Sanchez EP, Cox DL, Cosby D & Gomez-Sanchez CE 1995 Cloning, expression and tissue distribution of the rat NAD+-dependent 11β-hydroxysteroid dehydrogenase. Endocrinology 136 3729-3734.